Payment overview · 2025
General Payments
$132.69
10 reported records · 3 companies
Healthcare provider profile · identity verified
Aaron W Karr, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · SHEFFIELD, AL · NPI 1265428031
Verified facts
What the public records show
CMS Open Payments records show Aaron W Karr, D.O. received $132.69 in general payments during 2025 across 10 reported records.
Corcept Therapeutics accounted for 41.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $55.37 | 41.7% | 3 | 2025 |
| Indivior Inc. | Unresolved — no canonical attribution shown | $53.07 | 40.0% | 3 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $24.25 | 18.3% | 4 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $132.69 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $55.37 | 3 | 2025 |
Source payment records
|
|||||
| SUBLOCADE Normalized: sublocade |
Drug | Indivior Inc. | $53.07 | 3 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $24.25 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 774 | 188 |
| Gabapentin | Gabapentin | 632 | 161 |
| Omeprazole | Omeprazole | 308 | 77 |
| Pregabalin | Pregabalin | 284 | 64 |
| Tramadol Hcl | Tramadol Hcl | 271 | 91 |
| Amlodipine Besylate | Amlodipine Besylate | 270 | 85 |
| Pantoprazole Sodium | Pantoprazole Sodium | 245 | 78 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 237 | 43 |
| Clonazepam | Clonazepam | 232 | 42 |
| Atorvastatin Calcium | Atorvastatin Calcium | 210 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 203 | 66 |
| Metformin Hcl | Metformin Hcl | 180 | 68 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 172 | 45 |
| Lorazepam | Lorazepam | 157 | 35 |
| Furosemide | Furosemide | 144 | 56 |
| Zolpidem Tartrate | Zolpidem Tartrate | 144 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 143 | 54 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 133 | 52 |
| Metoprolol Succinate | Metoprolol Succinate | 127 | 50 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 124 | 35 |
| Meloxicam | Meloxicam | 123 | 42 |
| Buspirone Hcl | Buspirone Hcl | 118 | 40 |
| Sertraline Hcl | Sertraline Hcl | 118 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 38 |
| Trazodone Hcl | Trazodone Hcl | 115 | 42 |
| Mounjaro | Tirzepatide | 102 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 101 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 100 | 41 |
| Losartan Potassium | Losartan Potassium | 99 | 30 |
| Aripiprazole | Aripiprazole | 96 | 32 |
| Lisinopril | Lisinopril | 95 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 94 | 34 |
| Potassium Chloride | Potassium Chloride | 88 | 37 |
| Azithromycin | Azithromycin | 87 | 68 |
| Eszopiclone | Eszopiclone | 87 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 87 | 24 |
| Baclofen | Baclofen | 85 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 85 | 28 |
| Allopurinol | Allopurinol | 79 | 26 |
| Simvastatin | Simvastatin | 79 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 76 | 29 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 74 | 22 |
| Methylprednisolone | Methylprednisolone | 74 | 60 |
| Ondansetron Hcl | Ondansetron Hcl | 73 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 71 | 19 |
| Ibuprofen | Ibuprofen | 70 | 42 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 69 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 68 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 67 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 67 | 20 |
| Jardiance | Empagliflozin | 63 | 19 |
| Eliquis | Apixaban | 62 | 19 |
| Ozempic | Semaglutide | 61 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 60 | 17 |
| Trulicity | Dulaglutide | 57 | 14 |
| Carvedilol | Carvedilol | 56 | 21 |
| Bupropion Xl | Bupropion Hcl | 55 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 55 | 19 |
| Cefdinir | Cefdinir | 54 | 47 |
| Donepezil Hcl | Donepezil Hcl | 54 | 13 |
| Alprazolam | Alprazolam | 53 | 23 |
| Spironolactone | Spironolactone | 53 | 14 |
| Montelukast Sodium | Montelukast Sodium | 52 | 20 |
| Alendronate Sodium | Alendronate Sodium | 50 | 14 |
| Promethazine Hcl | Promethazine Hcl | 50 | 16 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 49 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | 18 |
| Amoxicillin | Amoxicillin | 47 | 40 |
| Hydralazine Hcl | Hydralazine Hcl | 46 | 17 |
| Indomethacin | Indomethacin | 45 | 15 |
| Diazepam | Diazepam | 43 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 43 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 42 | 21 |
| Levetiracetam | Levetiracetam | 42 | suppressed |
| Januvia | Sitagliptin Phosphate | 41 | 12 |
| Sucralfate | Sucralfate | 41 | 22 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | 19 |
| Propranolol Hcl | Propranolol Hcl | 40 | 16 |
| Zubsolv | Buprenorphine Hcl/Naloxone Hcl | 40 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 39 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 39 | 11 |
| Ezetimibe | Ezetimibe | 38 | 12 |
| Mirtazapine | Mirtazapine | 38 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 32 |
| Fluconazole | Fluconazole | 36 | 21 |
| Meclizine Hcl | Meclizine Hcl | 36 | 13 |
| Methocarbamol | Methocarbamol | 35 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 34 | 17 |
| Prednisone | Prednisone | 34 | 29 |
| Linzess | Linaclotide | 33 | 11 |
| Warfarin Sodium | Warfarin Sodium | 33 | suppressed |
| Memantine Hcl | Memantine Hcl | 32 | suppressed |
| Celecoxib | Celecoxib | 31 | 13 |
| Topiramate | Topiramate | 31 | suppressed |
| Fluocinonide | Fluocinonide | 29 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Fenofibrate | Fenofibrate | 27 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 26 | suppressed |
| Pentoxifylline | Pentoxifylline | 26 | suppressed |
| Primidone | Primidone | 26 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 26 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 25 | suppressed |
| Atenolol | Atenolol | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Famotidine | Famotidine | 22 | 11 |
| Glimepiride | Glimepiride | 22 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 22 | 21 |
| Fluocinonide-E | Fluocinonide/Emollient Base | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 20 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | suppressed |
| Belsomra | Suvorexant | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | 14 |
| Risperidone | Risperidone | 19 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 18 | 14 |
| Nystatin | Nystatin | 18 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 16 | suppressed |
| Olanzapine | Olanzapine | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 13 |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 11 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Vascepa | Icosapent Ethyl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $132.69 · 10 records | Corcept Therapeutics | Korlym, SUBLOCADE, VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error